Clinical Trial to study effect of Vitamin D3 levels in hair loss of more than 6 months duratio
Not Applicable
- Conditions
- Health Condition 1: L650- Telogen effluvium
- Registration Number
- CTRI/2023/09/057924
- Lead Sponsor
- Amrit Malik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients giving written informed consent for the study
2. All female patients coming to dermatology OPD of age 18 and above diagnosed with Chronic Telogen Effluvium who have not taken any treatment or supplements in the last 4 weeks
3. Healthy females will be taken as controls and matched with age
Exclusion Criteria
1. Patients with signs other types of alopecia
2. Pregnant and lactating females
3. Women having any malignancy, systemic or local scalp disease
4. Female with previous history of multivitamin supplementation or taking drugs that may alter
Vitamin D3 in the last 4 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.level of vitamin d3 correlated with duration of symptoms in chronic telogen effluviumTimepoint: 12 months
- Secondary Outcome Measures
Name Time Method 1. to find any associated dermatoses in patients with low vitamin d3Timepoint: 12 months